Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances
Umm E Laila, Zi Lon Zhao, Huai Liu, Zhi-Xiang Xu School of Life Sciences, Henan University, Kaifeng, Henan Province, 475001, People’s Republic of ChinaCorrespondence: Zhi-Xiang Xu, School of Life Sciences, Henan University, Kaifeng, People’s Republic of China, Email zhixiangxu08@gmail.comAbstract: A...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/aspirin-in-cancer-therapy-pharmacology-and-nanotechnology-advances-peer-reviewed-fulltext-article-IJN |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Umm E Laila, Zi Lon Zhao, Huai Liu, Zhi-Xiang Xu School of Life Sciences, Henan University, Kaifeng, Henan Province, 475001, People’s Republic of ChinaCorrespondence: Zhi-Xiang Xu, School of Life Sciences, Henan University, Kaifeng, People’s Republic of China, Email zhixiangxu08@gmail.comAbstract: Aspirin, a non-steroidal anti-inflammatory drug (NSAID), has garnered significant attention for its anti-cancer potential. This review explores the pharmacological properties, chemical dynamics, and evolving therapeutic applications of aspirin, with an emphasis on its integration into advanced cancer therapies. Aspirin demonstrates broad-spectrum efficacy across diverse cancer types by modulating signaling pathways such as COX-dependent and COX-independent mechanisms, including Wnt, NF-κB, β-catenin/TCF, and IL-6/STAT3. Recent advancements highlight the role of nanotechnology in enhancing aspirin’s targeted delivery, therapeutic effectiveness, and patient outcomes. Nanoparticle-based formulations, including liposomes, solid lipid nanoparticles, and mesoporous silica nanoparticles, offer improved solubility, stability, and bioavailability, enabling controlled drug release and tumor-specific targeting. These innovations reduce systemic toxicity and enhance therapeutic effects, paving the way for aspirin’s integration into personalized cancer treatments. Ongoing clinical studies reinforce its safety profile, underscoring aspirin’s role in cancer pharmacotherapy. This review calls for continued research into aspirin’s repurposing in combination therapies and novel delivery systems to maximize its therapeutic potential.Keywords: aspirin, cancer therapy, signaling pathways, nanotechnology, targeted drug delivery |
|---|---|
| ISSN: | 1178-2013 |